NO172439C - Fremgangsmaate for fremstilling av tetrazolforbindelser ogforbindelse som anvendes i fremgangsmaaten - Google Patents

Fremgangsmaate for fremstilling av tetrazolforbindelser ogforbindelse som anvendes i fremgangsmaaten

Info

Publication number
NO172439C
NO172439C NO890661A NO890661A NO172439C NO 172439 C NO172439 C NO 172439C NO 890661 A NO890661 A NO 890661A NO 890661 A NO890661 A NO 890661A NO 172439 C NO172439 C NO 172439C
Authority
NO
Norway
Prior art keywords
procedure
tetrazolic
preparing
compounds
connections used
Prior art date
Application number
NO890661A
Other languages
English (en)
Norwegian (no)
Other versions
NO890661L (no
NO172439B (no
NO890661D0 (no
Inventor
William Teh-Wei Han
John Jessen Wright
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO890661D0 publication Critical patent/NO890661D0/no
Publication of NO890661L publication Critical patent/NO890661L/no
Priority to NO922392A priority Critical patent/NO175636C/no
Priority to NO923358A priority patent/NO174850C/no
Publication of NO172439B publication Critical patent/NO172439B/no
Publication of NO172439C publication Critical patent/NO172439C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
NO890661A 1988-02-18 1989-02-16 Fremgangsmaate for fremstilling av tetrazolforbindelser ogforbindelse som anvendes i fremgangsmaaten NO172439C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO922392A NO175636C (no) 1988-02-18 1992-06-18 6-formyl-1,3-dioksan-4-eddiksyreforbindelse, fremgangsmåte til fremstilling derav samt mellomprodukt til anvendelse ved fremgangsmåten
NO923358A NO174850C (no) 1988-02-18 1992-08-27 6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/156,865 US4824959A (en) 1988-02-18 1988-02-18 Intermediates for antihypercholesterolemic tetrazole compounds

Publications (4)

Publication Number Publication Date
NO890661D0 NO890661D0 (no) 1989-02-16
NO890661L NO890661L (no) 1989-08-21
NO172439B NO172439B (no) 1993-04-13
NO172439C true NO172439C (no) 1993-07-21

Family

ID=22561419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890661A NO172439C (no) 1988-02-18 1989-02-16 Fremgangsmaate for fremstilling av tetrazolforbindelser ogforbindelse som anvendes i fremgangsmaaten

Country Status (32)

Country Link
US (1) US4824959A (hu)
JP (2) JP2871707B2 (hu)
KR (1) KR970002233B1 (hu)
CN (1) CN1025619C (hu)
AT (1) AT401057B (hu)
AU (1) AU621586B2 (hu)
BE (1) BE1002136A5 (hu)
CA (1) CA1340430C (hu)
CH (1) CH680792A5 (hu)
CY (1) CY1874A (hu)
DD (4) DD285600A5 (hu)
DE (1) DE3904899A1 (hu)
DK (1) DK75289A (hu)
EG (1) EG19217A (hu)
ES (1) ES2017810A6 (hu)
FI (1) FI890725A (hu)
FR (1) FR2630112B1 (hu)
GB (1) GB2216121B (hu)
GR (1) GR1000664B (hu)
HK (3) HK129395A (hu)
HU (2) HU204045B (hu)
IE (1) IE65090B1 (hu)
IT (1) IT1230750B (hu)
LU (1) LU87456A1 (hu)
MY (1) MY106279A (hu)
NL (1) NL8900397A (hu)
NO (1) NO172439C (hu)
NZ (1) NZ227935A (hu)
PT (1) PT89748B (hu)
SE (2) SE503179C2 (hu)
YU (1) YU34189A (hu)
ZA (1) ZA891239B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
GB2244706B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole intermediates
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
DE4128345C1 (en) * 1991-08-27 1993-06-09 Hoechst Ag, 6230 Frankfurt, De 3R,5S 3,5,6-tri:hydroxy-hexanoic acid isopropylidene ketal derivs. prepn. - from 7-benzyl:oxy 4,6-di:hydroxy:heptene by multistage process
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE10147030A1 (de) * 2001-09-04 2003-03-27 Forschungszentrum Juelich Gmbh Verfahren zur Trennung diastereomerer 1,3-Diol-Acetale
US20050272808A1 (en) * 2004-05-11 2005-12-08 Nadav Zamir Compositions and methods for the treatment of hypertension
EP1746988A1 (en) * 2004-05-11 2007-01-31 Darley Pharmaceuticals Ltd. Spiroderivatives for the treatment of hypertension
CN104303915B (zh) * 2014-08-25 2016-05-25 李世峰 一种机插水稻水浮式育秧技术

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58225085A (ja) * 1982-06-24 1983-12-27 Nippon Kayaku Co Ltd アセタ−ルグリコ−ルジアクリレ−トおよびその製造法
US4808621A (en) * 1986-07-07 1989-02-28 Warner-Lambert Company Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4837205A (en) * 1986-09-02 1989-06-06 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4751229A (en) * 1987-07-09 1988-06-14 Warner-Lambert Company Treating fungal infections with substituted-(6-(tetrahydro-4-hydroxy-2-oxo-2H-pyran-2-yl)ethyl)- or ethenyl)pyrazoles
DE3807929A1 (de) * 1988-03-10 1989-09-28 Basf Ag Verfahren zur herstellung von reliefformen

Also Published As

Publication number Publication date
IT8919474A0 (it) 1989-02-17
AU3007589A (en) 1989-08-24
YU34189A (en) 1991-02-28
NL8900397A (nl) 1989-09-18
GR1000664B (el) 1992-09-25
DD283618A5 (de) 1990-10-17
SE8900565L (sv) 1989-08-19
HU209905B (en) 1994-11-28
SE9300595D0 (sv) 1993-02-23
HK47596A (en) 1996-03-29
MY106279A (en) 1995-04-29
KR890012992A (ko) 1989-09-20
SE9300595A0 (sv) 1993-02-23
GB8903604D0 (en) 1989-04-05
DD285600A5 (de) 1990-12-19
EG19217A (en) 1995-09-30
HUT50809A (en) 1990-03-28
HUT50167A (en) 1989-12-28
HK129295A (en) 1995-08-24
CH680792A5 (hu) 1992-11-13
CY1874A (en) 1996-04-05
DK75289D0 (da) 1989-02-17
JP2871707B2 (ja) 1999-03-17
IE65090B1 (en) 1995-10-04
FI890725A (fi) 1989-08-19
JP2922887B2 (ja) 1999-07-26
CN1025619C (zh) 1994-08-10
GB2216121A (en) 1989-10-04
AU621586B2 (en) 1992-03-19
FI890725A0 (fi) 1989-02-15
NO890661L (no) 1989-08-21
HK129395A (en) 1995-08-24
IE890523L (en) 1989-08-18
ES2017810A6 (es) 1991-03-01
NO172439B (no) 1993-04-13
ATA36189A (de) 1995-10-15
CN1036013A (zh) 1989-10-04
FR2630112B1 (fr) 1994-07-29
LU87456A1 (fr) 1989-09-20
DD285603A5 (de) 1990-12-19
SE8900565D0 (sv) 1989-02-17
JPH115791A (ja) 1999-01-12
SE503179C2 (sv) 1996-04-15
JPH01249771A (ja) 1989-10-05
HU204045B (en) 1991-11-28
PT89748B (pt) 1994-05-31
US4824959A (en) 1989-04-25
NZ227935A (en) 1990-07-26
ZA891239B (en) 1991-12-24
PT89748A (pt) 1989-10-04
AT401057B (de) 1996-06-25
DE3904899A1 (de) 1989-08-31
BE1002136A5 (fr) 1990-07-24
DD285602A5 (de) 1990-12-19
FR2630112A1 (fr) 1989-10-20
NO890661D0 (no) 1989-02-16
DK75289A (da) 1989-08-19
GB2216121B (en) 1992-07-15
IT1230750B (it) 1991-10-29
CA1340430C (en) 1999-03-09
KR970002233B1 (ko) 1997-02-26

Similar Documents

Publication Publication Date Title
DE3368929D1 (de) 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
DK298789A (da) Blaesestoebt flaske i et stykke og fremgangsmaade til fremstilling af samme
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO895194D0 (no) Fremgangsmaate for fremstilling av piperidinderivater.
NO890969D0 (no) Fremgangsmaate for fremstilling av isoindolinderivater.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO172439C (no) Fremgangsmaate for fremstilling av tetrazolforbindelser ogforbindelse som anvendes i fremgangsmaaten
NO894649L (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO171910C (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler
NO891588D0 (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
NO890330D0 (no) Fremgangsmaate til fremstilling av forbindelser med psykotrop virkning.
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO895040L (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
IT1227462B (it) Procedimento di preparazione di 6-ossopenicillanati
MX15265A (es) Colorantes reactivos y procedimiento para su preparacion
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
ATA47089A (de) Verschlussvorrichtung
FI904268A0 (fi) Anordning foer arbeten i t.ex. roerledningar.
ATA290588A (de) Verschlusseinrichtung
NO912279D0 (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
IT1203935B (it) Derivati-lattonici e procedimento per preparare gli stessi
NO883120L (no) Fremgangsmaate for aa redusere gjennomtrengeligheten av sterkt gjennomtrengelige soner i en undergrunnsformasjon.

Legal Events

Date Code Title Description
MK1K Patent expired